MedTrace Logo

Effectiveness Of Symbiotic Therapy In Jaundiced Patients

NCT01683708 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-09-12

No results posted yet for this study

Summary

The aim of the present study was therefore to evaluate if the perioperative administration of symbiotics reduces postoperative infectious morbidity in jaundiced patients scheduled for hepato-biliary and pancreatic surgery.

Conditions

  • Postoperative Infections
  • Jaundice

Interventions

DIETARY_SUPPLEMENT

Symbiotic therapy

Patients randomized into the Symbiotic group received Prebiotic® in a dose of one sachet twice a day for at least 1 week preoperatively. Postoperatively the medication was reintroduced as tolerated, and continued until discharge from hospital. One 4,5 gr sachet of Prebiotic® contains at least 1010 living Bifidobacterium bifidum, 1010 living Streptococcus Thermophilus, 1010 living Streptococcus Salivarius, 3 109 Lactobacillus Acidophilus, 1010 living Lactobacillus Casei, 1010 living Lactobacillus bulgaricus and galactooligosaccharides (4,5 gr).

Sponsors & Collaborators

  • Azienda Ospedaliera Ordine Mauriziano di Torino

    lead OTHER

Principal Investigators

  • Lorenzo Capussotti, MD · Mauriziano Hospital, Department of General and Oncological surgery

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683708 on ClinicalTrials.gov